We are live on ! Find out more
WAM

Warberg Asset Management Portfolio holdings

AUM $600M
1-Year Est. Return 23.37%
This Fund
S&P 500
This Quarter Est. Return
-0.04%
1 Year Est. Return
+23.37%
3 Year Est. Return
+49.78%
5 Year Est. Return
+106.43%
10 Year Est. Return
AUM
$562M
AUM Growth
-$96.3M
Cap. Flow
-$338M
Cap. Flow %
-60.12%
Top 10 Hldgs %
53.46%
Holding
270
New
50
Increased
30
Reduced
42
Closed
60
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OCEAW
126
DELISTED
Ocean Biomediacal, Inc. Warrants
OCEAW
$8.26K ﹤0.01%
168,596
-4,300
-2% -$174
BTBDW icon
127
BT Brands Warrant
BTBDW
$143K
$8.09K ﹤0.01%
117,882
SDEV
128
Stablecoin Development Corp
SDEV
$48.4M
$6.89K ﹤0.01%
+2,000
New +$9.89K
DFSCW
129
DEFSEC Technologies Warrant
DFSCW
$5.76K ﹤0.01%
345,141
-9,010
-3% -$232
PGYWW
130
Pagaya Technologies Ltd Warrants
PGYWW
$1.52M
$5.66K ﹤0.01%
30,000
SWAGW icon
131
Stran & Company Warrant
SWAGW
$5.52K ﹤0.01%
180,824
RBOT.WS
132
DELISTED
Vicarious Surgical Inc Warrants
RBOT.WS
$5.26K ﹤0.01%
112,000
CREVW
133
DELISTED
Carbon Revolution PLC Warrant
CREVW
$5.01K ﹤0.01%
172,022
IGTAW
134
DELISTED
Inception Growth Acquisition Limited Warrants
IGTAW
$3.96K ﹤0.01%
79,550
-500
-0.6% -$42
MRNOW
135
Murano Global Investments PLC Warrants
MRNOW
$118K
$3.95K ﹤0.01%
28,200
OGEN icon
136
Oragenics
OGEN
$2.48M
$3.86K ﹤0.01%
333
PIII icon
137
P3 Health Partners
PIII
$34.5M
$3.86K ﹤0.01%
+200
New +$5.24K
APLMW icon
138
Apollomics Inc Warrant
APLMW
$1.44M
$3.55K ﹤0.01%
438,787
-72,713
-14% -$851
NRSNW icon
139
NeuroSense Therapeutics Warrant
NRSNW
$3.71M
$3.43K ﹤0.01%
20,201
-11,805
-37% -$2.01K
APLM icon
140
Apollomics
APLM
$38.6M
$3.34K ﹤0.01%
+235
New +$3.76K
AERTW
141
Aeries Technology Warrant
AERTW
$887K
$3.04K ﹤0.01%
95,027
APCXW
142
DELISTED
AppTech Payments Corp Warrant
APCXW
$3K ﹤0.01%
13,804
-44,634
-76% -$14.4K
NVACW
143
DELISTED
NorthView Acquisition Corporation Warrant
NVACW
$2.92K ﹤0.01%
77,770
INUV icon
144
Inuvo
INUV
$18M
$2.47K ﹤0.01%
1,000
-1,000
-50% -$2.79K
HUBCW icon
145
Hub Cyber Security Warrant 2/27/28
HUBCW
$176K
$2.43K ﹤0.01%
171,171
PTIXW
146
DELISTED
Protagenic Therapeutics Warrant
PTIXW
$2.11K ﹤0.01%
177,196
SURGW
147
DELISTED
SurgePays, Inc. Warrant
SURGW
$1.88K ﹤0.01%
116,509
-250,196
-68% -$26K
LIXTW
148
DELISTED
Lixte Biotechnology Warrants
LIXTW
$1.6K ﹤0.01%
35,906
-1,968
-5% -$93
SXTPW icon
149
60 Degrees Pharmaceuticals Warrant
SXTPW
$37K
$1.51K ﹤0.01%
29,515
LEV.WS.A
150
DELISTED
The Lion Electric Company Warrants to purchase common shares
LEV.WS.A
$1.36K ﹤0.01%
17,000
-4,000
-19% -$356

Similar funds

Warberg Asset Management's Q3 2024 Portfolio in Review

As of Q3 2024, Warberg Asset Management held 270 positions worth $562M, down 15% from $658M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Warberg Asset Management withdrew a net $338M in Q3 2024, closing 60 positions and reducing 42 holdings. Its most notable exit was Trump Media & Technology Group Warrants, an estimated $8.41M position sold in full.

By sector, the portfolio is most concentrated in Financials at 2% of assets, up from 1.5% a quarter earlier, followed by Healthcare and Energy.

Against the trend, Warberg Asset Management opened a new position in iShares 0-3 Month Treasury Bond ETF worth $5.08M.

  • Warberg Asset Management's largest Q3 2024 buy was iShares 0-3 Month Treasury Bond ETF: 50,455 shares worth $5.08M.
  • Warberg Asset Management added most to Grayscale Bitcoin Trust in Q3 2024, an estimated $511K increase.
  • Warberg Asset Management's biggest Q3 2024 reduction was Occidental Petroleum Corp Warrants, cutting an estimated $3.94M.
  • Warberg Asset Management fully exited Trump Media & Technology Group Warrants in Q3 2024, selling an estimated $8.41M.
  • Warberg Asset Management's ten largest holdings make up 53% of its $562M portfolio in Q3 2024.
  • Warberg Asset Management opened 50 new positions and closed 60 in Q3 2024.
  • Warberg Asset Management's portfolio value fell 15% quarter-over-quarter to $562M.

Based on Warberg Asset Management's 13F filing for Q3 2024, filed 6 Nov 2024.